Multifunctional Biomimetic Nanotherapeutics for Anti‐Oxidative and Anti‐Inflammatory Synergistic Therapy of Corneal Neovascularization

Multifunctional Biomimetic Nanotherapeutics for Anti‐Oxidative and Anti‐Inflammatory Synergistic Therapy of Corneal Neovascularization

ABSTRACT Corneal neovascularization (CNV) is a debilitating ocular surface disease that severely compromises visual function and carries a significant risk of vision loss. Despite its clinical impact, the development of effective and safe pharmacological treatments for CNV remains an unmet medical n...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shundong Cai, Mengdie Li, Jinfa Ye, Mingyou Zhang, Jingbin Zhuang, Yuhang Cheng, Hongjin Li, Lang Ke, Xingyuan Wei, Yun Han, Huanhuan Liu, Gang Liu, Chengchao Chu
Format:	Article
Language:	English
Published:	Wiley 2025-06-01
Series:	Aggregate
Subjects:	anti‐inflammatory therapy anti‐oxidative therapy biomimetic nanomedicine corneal neovascularization vanadium carbide
Online Access:	https://doi.org/10.1002/agt2.70034
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sonodynamic biomimetic-nanomedicine fight cancers
by: Anni Zhang, et al.
Published: (2025-07-01)

Nanotherapeutics for Macrophage Network Modulation in Tumor Microenvironments: Targets and Tools
by: Li R, et al.
Published: (2024-12-01)

Efficiency of antiangiogenic therapy for choroidal neovascularization in children
by: L. A. Katargina, et al.
Published: (2024-12-01)

Efficiency of surgical treatment of neovascular glaucoma: a retrospective analysis
by: A. V. Zolotarev, et al.
Published: (2023-07-01)

Myopic choroidal neovascularization with dilated choroid vessels is prone to progression into subretinal fibrosis following anti-vascular endothelial growth factor therapy: a retrospective study
by: Xiangjun She, et al.
Published: (2025-08-01)

Clinical Evaluation of the Effectiveness of Neovascular Age-related Macular Degeneration Combined Treatment
by: L. A. Golota, et al.
Published: (2025-03-01)

Short-term Outcomes of Anti-VEGF therapy in Neovascular Age-related Macular Degeneration with Initially Low Visual Acuity
by: A. N. Kulikov, et al.
Published: (2025-03-01)

Analysis of Clinical Study Results Obtained in Patients with Neovascular Age-Related Macular Degeneration in 2005–2020. Review
by: N. A. Gavrilova, et al.
Published: (2022-04-01)

Corneal neovascularization: a modern view of molecular mechanisms and methods of therapy
by: G. S. Arzhimatova, et al.
Published: (2023-07-01)

Use of Bevacizumab in the Treatment of Corneal Neovascularization
by: Tuba Çelik, et al.
Published: (2015-01-01)

Tailored Anti-VEGF Therapy with New Generation Optimizations (TANGO) Treatment Regimen for Neovascular Age-Related Macular Degeneration: Rationale, Design, and Simulation Study
by: Subhi Y, et al.
Published: (2025-04-01)

The Vascular Architecture of Macular Neovascularization in Age-Related Macular Degeneration as a Predictor of Therapy Requirements: A 3-Year Longitudinal Analysis
by: Michael Grün, et al.
Published: (2025-04-01)

Kavain Alleviates Choroidal Neovascularization Via Decreasing the Activity of the HIF-1α/VEGF-A/VEGFR2 Signaling Pathway and Inhibiting Inflammation
by: Xi Chen, et al.
Published: (2024-07-01)

Thymoquinone as a Natural Anti-Angiogenic Agent: Experimental Pharmacology insights into Schematic and Meta-Analysis of Ocular Neovascularization and Retinal Pathology
by: Soobia Pathan, et al.
Published: (2025-07-01)

Optical Coherent Tomography-Angiography in the Research of Myopia Complicated by Choroidal Neovascularization
by: E. A. Drozdova, et al.
Published: (2020-09-01)

Evidence for Whom? A Systematic Review of Eligibility Criteria in RCTs of Anti-VEGF for Neovascular Age-Related Macular Degeneration
by: Andreas Arnold-Vangsted, et al.
Published: (2025-07-01)

Atypical choroidal neovascular membrane
by: Kimia Rezaei, et al.
Published: (2024-12-01)

Efficacy and Safety of Aflibercept Biosimilars Relative to Reference Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
by: Aljuhani HS, et al.
Published: (2025-06-01)

The first Russian register of patients with neovascular age-related macular degeneration: a real-world clinical study
by: V. V. Neroev, et al.
Published: (2023-12-01)

Pharmacological Analysis of Resistance to Anti-VEGF Therapy
by: M. V. Budzinskaya, et al.
Published: (2019-01-01)

Incidence and Clinical Practice of Myopic Macular Neovascularization: A Nationwide Population-Based Cohort Study
by: Masahiro Akada, MD, et al.
Published: (2025-11-01)

Outcomes of Anti-VEGF Therapy in Eyes with Diabetic Macular Edema, Vein Occlusion-Related Macular Edema, and Neovascular Age-Related Macular Degeneration: A Systematic Review
by: Aldokhail LS, et al.
Published: (2024-12-01)

Synergistic HER2-scFv mediated immunotherapy with targeted gemcitabine delivery harnessing biomimetic composite nanoparticles for enhanced metastatic tumor therapy
by: Xinan Wang, et al.
Published: (2025-06-01)

Photodynamic therapy for neovascular age-related macular degeneration
by: Richard P.L. Wormald, MA, MB, BCh, MSc, FRCS, FRCOphth, et al.
Published: (2005-06-01)

Analysis of the etiology, clinical characteristics and treatment outcomes of choroidal neovascularization in Chinese children and adolescents
by: Shenshen Yan, et al.
Published: (2025-04-01)

The effect of a specific vitamin supplement containing L-methylfolate (Ocufolin forte) in patients with neovascular age-related macular degeneration
by: Tatjana Josifova, et al.
Published: (2025-05-01)

Targeted and Biomimetic Nanoparticles for Atherosclerosis Therapy: A Review of Emerging Strategies
by: Dorota Bartusik-Aebisher, et al.
Published: (2025-07-01)

Inhibition of retinal neovascularization by Dendrobium polysaccharides: a review
by: Dan Liu, et al.
Published: (2025-06-01)

Results of combined antiangiogenic activity on corneal neovascularization. Experimental and morphological study
by: V. R. Mamikpnyan, et al.
Published: (2014-09-01)

Retinal sensitivity above macular neovascularization under anti-VEGF therapy in exudative neovascular age-related macular degeneration
by: Laurenz Pauleikhoff, et al.
Published: (2025-03-01)

Photoresponsive Multirole Nanoweapon Camouflaged by Hybrid Cell Membrane Vesicles for Efficient Antibacterial Therapy of Pseudomonas aeruginosa‐Infected Pneumonia and Wound
by: Hening Liu, et al.
Published: (2024-09-01)

Optical Coherence Tomography Angiography (OCTA) information content in the diagnosis of type 1 choroidal neovascularization combined with pigment epithelium detachment
by: V. V. Neroev, et al.
Published: (2021-03-01)

Neovascular Glaucoma as the First Symptom of Bilateral Occlusive Retinal Vasculitis in a 4-Year-Old Girl: A Case Report
by: Klaudia Rakusiewicz-Krasnodębska, et al.
Published: (2025-01-01)

Long-Term Outcomes of Nonadherence to Anti-VEGF Therapy in Advanced Neovascular Age-Related Macular Degeneration
by: A. N. Kulikov, et al.
Published: (2022-10-01)

Anti Vascular Endothelial Growth Factor Agents in Corneal Neovascularization
by: Srivatsa Sehra, et al.
Published: (2011-07-01)

Intravitreal bevacizumab for neovascular age-related macular degeneration
by: Junn R. Pajarillo, MD, et al.
Published: (2009-12-01)

Biomimetic mineralized DCPA/ anti-CD47 containing thermo-sensitive injectable hydrogel for bone-metastatic prostate cancer treatment
by: Shenglong Tan, et al.
Published: (2025-04-01)

A Comparative Study about Production of Va nadium Carbide via Self Propagating High Temperature Synthesis and Reduction
by: Mehmet Bugdayci, et al.
Published: (2024-04-01)

Comparative efficacy and safety of Faricimab with other intravitreal anti-vascular endothelial growth factor in the treatment of Neovascular age related macular degeneration- A Systematic review and meta-analysis
by: Renuga Devi Kaliaperumal, et al.
Published: (2025-05-01)

THE ROLE OF ANTI-VEGF THERAPY IN IMPROVING THE EFFICACY OF SURGICAL TREATMENT OF SECONDARY NEOVASCULAR GLAUCOMA
by: Uliana Sydorchuk, et al.
Published: (2024-10-01)